Relmada spikes as Steve Cohen’s Point72 discloses 7% stake

Oct. 17, 2022 1:33 PM ETRelmada Therapeutics, Inc. (RLMD)By: Dulan Lokuwithana, SA News Editor1 Comment

Wall Street New York City

aluxum/E+ via Getty Images

  • Relmada Therapeutics (NASDAQ:RLMD) added more than 8% into afternoon trading Monday after Point72 Asset Management, run by billionaire fund manager Steven Cohen disclosed 7.3% ownership in the clinical-stage biotech.
  • According to a 13-G filing submitted Monday, the

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.